Is earlier better? Translating clinical evidence into individualised treatment decisions in advanced prostate cancer


ESMO 2018 Industry satellite symposium


Scientific Committee:

Eleni Efstathiou, USA
Boris Hadaschik, Germany  


Noel Clarke, UK
Karim Fizazi, France
Eric Small, USA  



13:00 - 13:15
The evolving landscape in advanced prostate cancer: current open questions
Boris Hadaschik, Germany

13:15 - 13:45 
Individualising treatments in mHSPC: an option or a must? 
Karim Fizazi, France and Noel Clark, UK

13:45 - 14:15
nmCRPC: is treatment really needed?
Eric Small, USA

14:15 - 14:30 A look to the future of prostate cancer treatment
Eleni Efstathiou, USA

More Info
21 October 2018 1:00 PM CEST 91 Minutes
PHEM/ONCS/0618/002p - Date of preparation: October 2018